 Anthony Gerber
Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 16 | 2025 | 148 | 4.880 |
Why?
| | Glucocorticoids | 12 | 2025 | 580 | 2.690 |
Why?
| | Dexamethasone | 10 | 2022 | 350 | 2.260 |
Why?
| | Transcription, Genetic | 9 | 2025 | 1418 | 1.790 |
Why?
| | Kruppel-Like Transcription Factors | 7 | 2020 | 67 | 1.740 |
Why?
| | NF-kappa B | 10 | 2024 | 665 | 1.680 |
Why?
| | Muscle, Smooth | 4 | 2019 | 161 | 1.540 |
Why?
| | Asthma | 12 | 2025 | 2225 | 1.470 |
Why?
| | Nuclear Proteins | 6 | 2017 | 660 | 1.390 |
Why?
| | Enhancer Elements, Genetic | 5 | 2025 | 176 | 1.330 |
Why?
| | Gene Expression Regulation | 14 | 2025 | 2542 | 1.240 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2024 | 1202 | 1.170 |
Why?
| | Transcription Factors | 4 | 2022 | 1647 | 1.070 |
Why?
| | Receptors, Aryl Hydrocarbon | 3 | 2025 | 49 | 0.990 |
Why?
| | Anti-Inflammatory Agents | 3 | 2022 | 482 | 0.980 |
Why?
| | Airway Remodeling | 2 | 2017 | 64 | 0.910 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 4 | 2016 | 11 | 0.900 |
Why?
| | Alveolar Epithelial Cells | 2 | 2022 | 107 | 0.880 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 3 | 2025 | 235 | 0.880 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2025 | 634 | 0.770 |
Why?
| | Mucin-5B | 3 | 2022 | 215 | 0.760 |
Why?
| | Signal Transduction | 11 | 2021 | 4931 | 0.750 |
Why?
| | Wood | 1 | 2021 | 15 | 0.740 |
Why?
| | Inflammation | 6 | 2022 | 2750 | 0.690 |
Why?
| | Particulate Matter | 1 | 2022 | 247 | 0.680 |
Why?
| | Smoke | 1 | 2021 | 140 | 0.670 |
Why?
| | RNA | 2 | 2025 | 882 | 0.630 |
Why?
| | Respiratory System | 2 | 2017 | 155 | 0.620 |
Why?
| | Bronchi | 3 | 2018 | 249 | 0.610 |
Why?
| | Repressor Proteins | 2 | 2021 | 406 | 0.610 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2025 | 2060 | 0.610 |
Why?
| | Epithelial Cells | 5 | 2024 | 1075 | 0.600 |
Why?
| | Hyperoxia | 1 | 2019 | 90 | 0.600 |
Why?
| | Proline Oxidase | 2 | 2015 | 6 | 0.590 |
Why?
| | Transcription Factor RelA | 3 | 2024 | 84 | 0.580 |
Why?
| | Response Elements | 2 | 2015 | 90 | 0.570 |
Why?
| | Phospholipase C delta | 1 | 2017 | 4 | 0.570 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 984 | 0.560 |
Why?
| | Airway Obstruction | 1 | 2019 | 152 | 0.560 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1445 | 0.560 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 524 | 0.530 |
Why?
| | Cell Line | 8 | 2021 | 2784 | 0.520 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 374 | 0.500 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.490 |
Why?
| | Triage | 1 | 2017 | 207 | 0.490 |
Why?
| | Homeodomain Proteins | 2 | 2018 | 494 | 0.480 |
Why?
| | Lung | 8 | 2024 | 3938 | 0.450 |
Why?
| | RNA, Messenger | 4 | 2020 | 2708 | 0.450 |
Why?
| | Genes, Reporter | 2 | 2017 | 265 | 0.430 |
Why?
| | Chromatin | 3 | 2022 | 479 | 0.410 |
Why?
| | Drug Discovery | 2 | 2016 | 130 | 0.410 |
Why?
| | Gene Expression | 3 | 2022 | 1465 | 0.410 |
Why?
| | Prednisolone | 1 | 2013 | 82 | 0.410 |
Why?
| | RNA Polymerase II | 5 | 2021 | 318 | 0.410 |
Why?
| | Introns | 1 | 2014 | 251 | 0.410 |
Why?
| | Machine Learning | 1 | 2017 | 443 | 0.400 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 217 | 0.400 |
Why?
| | Binding Sites | 5 | 2021 | 1248 | 0.390 |
Why?
| | Genomics | 3 | 2022 | 718 | 0.390 |
Why?
| | Humans | 44 | 2025 | 129626 | 0.380 |
Why?
| | Cytokines | 3 | 2022 | 2021 | 0.360 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 441 | 0.350 |
Why?
| | Bronchial Hyperreactivity | 1 | 2011 | 109 | 0.340 |
Why?
| | Protein Binding | 6 | 2020 | 2124 | 0.320 |
Why?
| | Chromatin Immunoprecipitation | 4 | 2017 | 132 | 0.300 |
Why?
| | I-kappa B Kinase | 3 | 2024 | 54 | 0.300 |
Why?
| | Vitamin D | 1 | 2011 | 381 | 0.290 |
Why?
| | Models, Genetic | 2 | 2021 | 593 | 0.290 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 2 | 2018 | 36 | 0.280 |
Why?
| | A549 Cells | 3 | 2024 | 59 | 0.280 |
Why?
| | Cells, Cultured | 5 | 2019 | 4084 | 0.270 |
Why?
| | Transcriptional Activation | 3 | 2016 | 367 | 0.270 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 259 | 0.270 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 617 | 0.270 |
Why?
| | Animals | 14 | 2025 | 35391 | 0.260 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2274 | 0.250 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2342 | 0.240 |
Why?
| | Systems Biology | 1 | 2006 | 60 | 0.240 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 460 | 0.240 |
Why?
| | Promoter Regions, Genetic | 4 | 2017 | 1207 | 0.240 |
Why?
| | Lung Diseases | 2 | 2015 | 741 | 0.230 |
Why?
| | Base Sequence | 4 | 2017 | 2147 | 0.230 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 310 | 0.220 |
Why?
| | Diagnostic Imaging | 1 | 2006 | 325 | 0.210 |
Why?
| | Transposases | 1 | 2022 | 17 | 0.200 |
Why?
| | Afghanistan | 1 | 2022 | 70 | 0.200 |
Why?
| | Mice | 7 | 2021 | 16961 | 0.200 |
Why?
| | Air Pollution | 1 | 2025 | 218 | 0.190 |
Why?
| | Cytochrome P-450 CYP1A1 | 1 | 2021 | 9 | 0.190 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2021 | 31 | 0.180 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 141 | 0.180 |
Why?
| | Biological Therapy | 2 | 2022 | 28 | 0.180 |
Why?
| | Toll-Like Receptor 2 | 1 | 2022 | 113 | 0.180 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 140 | 0.180 |
Why?
| | alpha 1-Antitrypsin | 1 | 2022 | 107 | 0.180 |
Why?
| | Respiratory Tract Diseases | 1 | 2022 | 148 | 0.180 |
Why?
| | PPAR gamma | 1 | 2022 | 183 | 0.180 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 34 | 0.180 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 276 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 53 | 0.180 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 100 | 0.170 |
Why?
| | Primary Cell Culture | 2 | 2019 | 164 | 0.170 |
Why?
| | Congresses as Topic | 2 | 2024 | 216 | 0.160 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 240 | 0.160 |
Why?
| | Corynebacterium Infections | 1 | 2020 | 40 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 194 | 0.160 |
Why?
| | Gene Silencing | 2 | 2016 | 190 | 0.150 |
Why?
| | Male | 10 | 2025 | 63670 | 0.150 |
Why?
| | Fluticasone | 1 | 2018 | 90 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 507 | 0.150 |
Why?
| | Mucins | 1 | 2018 | 70 | 0.150 |
Why?
| | Histidine Decarboxylase | 1 | 2017 | 5 | 0.140 |
Why?
| | Drug Resistance | 1 | 2018 | 165 | 0.140 |
Why?
| | Microphthalmia-Associated Transcription Factor | 1 | 2017 | 14 | 0.140 |
Why?
| | GATA2 Transcription Factor | 1 | 2017 | 14 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2019 | 181 | 0.140 |
Why?
| | Regeneration | 1 | 2019 | 182 | 0.140 |
Why?
| | Female | 9 | 2025 | 68734 | 0.140 |
Why?
| | Hypertrophy | 1 | 2017 | 122 | 0.140 |
Why?
| | Transduction, Genetic | 1 | 2017 | 131 | 0.130 |
Why?
| | Trachea | 1 | 2018 | 226 | 0.130 |
Why?
| | HEK293 Cells | 1 | 2019 | 698 | 0.130 |
Why?
| | Statistics as Topic | 1 | 2017 | 305 | 0.130 |
Why?
| | Feedback, Physiological | 1 | 2016 | 76 | 0.130 |
Why?
| | Adenoviridae | 1 | 2017 | 193 | 0.130 |
Why?
| | Mast Cells | 1 | 2017 | 142 | 0.130 |
Why?
| | Anaphylaxis | 1 | 2017 | 98 | 0.130 |
Why?
| | Lung Injury | 1 | 2019 | 211 | 0.130 |
Why?
| | Models, Biological | 4 | 2016 | 1724 | 0.130 |
Why?
| | Infant, Newborn | 2 | 2019 | 5756 | 0.120 |
Why?
| | Fibroblasts | 2 | 2025 | 953 | 0.120 |
Why?
| | Drug Monitoring | 1 | 2016 | 215 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2018 | 772 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 84 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 427 | 0.120 |
Why?
| | Administration, Inhalation | 1 | 2016 | 667 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 301 | 0.120 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2015 | 89 | 0.110 |
Why?
| | Disease Progression | 2 | 2023 | 2627 | 0.110 |
Why?
| | Cohort Studies | 1 | 2025 | 5426 | 0.110 |
Why?
| | Consensus | 1 | 2017 | 618 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 651 | 0.110 |
Why?
| | RNA Interference | 1 | 2016 | 450 | 0.110 |
Why?
| | Muscle, Skeletal | 2 | 2015 | 1613 | 0.110 |
Why?
| | Pulmonary Surfactants | 1 | 2015 | 106 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 949 | 0.110 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 103 | 0.110 |
Why?
| | Mice, Inbred C57BL | 3 | 2015 | 5455 | 0.110 |
Why?
| | Blotting, Western | 1 | 2016 | 1206 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 68 | 0.100 |
Why?
| | Immunotherapy | 1 | 2017 | 596 | 0.100 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 281 | 0.100 |
Why?
| | Precision Medicine | 1 | 2016 | 387 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 487 | 0.090 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 126 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2020 | 591 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2018 | 893 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1687 | 0.090 |
Why?
| | Transcriptome | 1 | 2017 | 876 | 0.090 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3186 | 0.090 |
Why?
| | Antibody Formation | 2 | 2022 | 291 | 0.090 |
Why?
| | Ovalbumin | 1 | 2011 | 178 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2835 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2017 | 2881 | 0.090 |
Why?
| | Algorithms | 1 | 2017 | 1616 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1366 | 0.080 |
Why?
| | Middle Aged | 2 | 2025 | 31136 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3080 | 0.080 |
Why?
| | Caproates | 1 | 2009 | 4 | 0.080 |
Why?
| | Aurintricarboxylic Acid | 1 | 2009 | 4 | 0.080 |
Why?
| | Toluidines | 1 | 2009 | 7 | 0.080 |
Why?
| | Budesonide | 2 | 2022 | 89 | 0.080 |
Why?
| | Rosaniline Dyes | 1 | 2009 | 12 | 0.080 |
Why?
| | Physicians | 1 | 2017 | 866 | 0.080 |
Why?
| | Anthracyclines | 1 | 2009 | 49 | 0.080 |
Why?
| | Adipogenesis | 1 | 2009 | 51 | 0.080 |
Why?
| | Lipid Metabolism | 1 | 2012 | 503 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 756 | 0.080 |
Why?
| | Biomarkers | 2 | 2017 | 3968 | 0.080 |
Why?
| | Biological Assay | 1 | 2009 | 118 | 0.070 |
Why?
| | Antibodies, Viral | 2 | 2022 | 602 | 0.070 |
Why?
| | Autonomic Nervous System | 2 | 2005 | 75 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 877 | 0.070 |
Why?
| | Fluorescent Dyes | 1 | 2009 | 312 | 0.070 |
Why?
| | Ligands | 1 | 2009 | 621 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2128 | 0.060 |
Why?
| | Tobacco, Smokeless | 1 | 2005 | 10 | 0.060 |
Why?
| | DNA Methylation | 2 | 2022 | 611 | 0.060 |
Why?
| | Macrophages | 2 | 2022 | 1488 | 0.060 |
Why?
| | Drug Therapy | 1 | 2005 | 80 | 0.060 |
Why?
| | Disease | 1 | 2005 | 95 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2373 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 13 | 0.050 |
Why?
| | Environment | 1 | 2005 | 348 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 60 | 0.050 |
Why?
| | Phenotype | 2 | 2024 | 3075 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 43 | 0.050 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2005 | 176 | 0.050 |
Why?
| | Adult | 1 | 2025 | 35599 | 0.050 |
Why?
| | Nicotine | 1 | 2005 | 302 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2016 | 10219 | 0.050 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 385 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2024 | 372 | 0.050 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 67 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 403 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 264 | 0.050 |
Why?
| | Exercise | 1 | 2012 | 1928 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 353 | 0.040 |
Why?
| | Young Adult | 1 | 2016 | 12455 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 939 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 546 | 0.040 |
Why?
| | Corynebacterium | 1 | 2020 | 48 | 0.040 |
Why?
| | Keratinocytes | 1 | 2020 | 243 | 0.040 |
Why?
| | Th1 Cells | 1 | 2018 | 137 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 10 | 0.040 |
Why?
| | Transfection | 1 | 2020 | 915 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 172 | 0.030 |
Why?
| | Smoking | 1 | 2005 | 1500 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 20412 | 0.030 |
Why?
| | Formoterol Fumarate | 1 | 2016 | 7 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 152 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 274 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 317 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2017 | 330 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1404 | 0.030 |
Why?
| | Canada | 1 | 2017 | 350 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1713 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2020 | 627 | 0.030 |
Why?
| | Eosinophils | 1 | 2017 | 324 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2011 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1011 | 0.030 |
Why?
| | Vaccination | 1 | 2022 | 1347 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 712 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1432 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5483 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 9786 | 0.020 |
Why?
| | United States | 2 | 2017 | 13871 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4078 | 0.020 |
Why?
| | Amino Acids | 1 | 2012 | 487 | 0.020 |
Why?
| | Homeostasis | 1 | 2012 | 605 | 0.020 |
Why?
| | Glucose | 1 | 2012 | 1002 | 0.020 |
Why?
| | Tachycardia | 1 | 2005 | 57 | 0.010 |
Why?
| | Biological Clocks | 1 | 2005 | 40 | 0.010 |
Why?
| | Tumor Escape | 1 | 2005 | 39 | 0.010 |
Why?
| | Vagus Nerve | 1 | 2005 | 86 | 0.010 |
Why?
| | Melatonin | 1 | 2005 | 125 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 10490 | 0.010 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 174 | 0.010 |
Why?
| | Th2 Cells | 1 | 2005 | 171 | 0.010 |
Why?
| | Life Style | 1 | 2005 | 461 | 0.010 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2005 | 151 | 0.010 |
Why?
| | Receptors, Nicotinic | 1 | 2005 | 327 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2005 | 413 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2005 | 408 | 0.010 |
Why?
| | Child | 1 | 2018 | 20884 | 0.010 |
Why?
| | Anxiety | 1 | 2005 | 972 | 0.010 |
Why?
| | Hypertension | 1 | 2005 | 1243 | 0.010 |
Why?
| | Neoplasms | 1 | 2005 | 2455 | 0.010 |
Why?
|
|
Gerber's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|